MU
54
6
COP
51
-2
XOM
51
-9
CAG
47
3
NOC
47
-6
SEE
46
2
CINF
41
-9
GOOG
97
14
OKE
71
-3
ROK
46
3
KEY
50
11
INTU
69
2
KLAC
65
6
AVY
77
2
MCD
62
10
FOX
33
-6
GILD
28
2
TRIP
75
9
APA
52
2
DRI
48
-12
MU
54
6
COP
51
-2
XOM
51
-9
CAG
47
3
NOC
47
-6
SEE
46
2
CINF
41
-9
GOOG
97
14
OKE
71
-3
ROK
46
3
KEY
50
11
INTU
69
2
KLAC
65
6
AVY
77
2
MCD
62
10
FOX
33
-6
GILD
28
2
TRIP
75
9
APA
52
2
DRI
48
-12
Financhill
Back

GlycoMimetics 10K Form

Sell
17

GLYC
GlycoMimetics

Last Price:
1.65
Seasonality Move:
17.46%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-03 10Q GLYC/GlycoMimetics Quarterly
2023-08-02 10Q GLYC/GlycoMimetics Quarterly
2023-05-03 10Q GLYC/GlycoMimetics Quarterly
2022-11-09 10Q GLYC/GlycoMimetics Quarterly
2022-08-03 10Q GLYC/GlycoMimetics Quarterly
2022-04-28 10Q GLYC/GlycoMimetics Quarterly

Receive GLYC News And Ratings

See the #1 stock for the next 7 days that we like better than GLYC

GLYC Financial Statistics

Sales & Book Value

Annual Sales: $10K
Cash Flow: $-7.62M
Price / Cash Flow: 0
Annual Sales: $0.60
Price / Book: 2.75

Profitability

EPS (TTM): -0.58000
Net Income (TTM): $-36.9M
Gross Margin: $0
Return on Equity: -75.34%
Return on Assets: -65.64%

GlycoMimetics Earnings Forecast

Key GlycoMimetics Financial Ratios

  • The Gross Profit Margin over the past 4 years for GLYC is 0.00%.
  • The Selling, General & Administrative Expenses for GLYC have been equal to 192,130.00% of Gross Profit Margin.
  • The Research & Development expenses have been 200,716.60% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of GLYC is -368,994.20% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 6 years.

GlycoMimetics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: GLYC
CUSIP: 38000Q
Website: glycomimetics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 6.41
Quick Ratio: 6.14

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

GLYC Technical Analysis vs Fundamental Analysis

Sell
17
GlycoMimetics (GLYC) is a Sell

Is GlycoMimetics a Buy or a Sell?

  • GlycoMimetics stock is rated a Sell
    The current GlycoMimetics [GLYC] share price is $1.64. The Score for GLYC is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.